Addictions, Drug & Alcohol Institute

Methamphetamine in Washington Symposium 2019

The University of Washington Alcohol & Drug Abuse Institute, with support from the Washington HCA Division of Behavioral Health & Recovery, hosted a symposium on Methamphetamine in Washington: Informing Policy and Research, in June 2019, with over 130 participants. A diverse group of speakers presented current information on the scope and impact of meth use, with a goal to address gaps in our understanding, and strategies for dealing with this large and growing issue in Washington State.

ResourceMethamphetamine in Washington: Report to the Division of Behavioral Health and Recovery, Washington State Department of Social and Health Services. SA Stoner, JR Williams, A Newman, N Sutherland, C Banta-Green. Seattle, WA: Alcohol & Drug Abuse Institute, University of Washington, June 2018.

Morning Session

Opening Remarks & Welcome (14 min.)

Open video in new tab

  • Caleb Banta-Green, PhD, MPH, MSW, UW Alcohol & Drug Abuse Institute [0:00:00 | slides]
  • Sally Clark, UW Regional & Community Relations [0:03:58]
  • Charissa Fotinos, MD, MSC, Washington State Health Care Authority [0:08:15]

What We Can Learn from People Who’ve Been There(30 min.)

Open video in new tab

Moderator: Susan Kingston, UW Alcohol & Drug Abuse Institute

Conversation with individuals with lived experience of methamphetamine.

Scope and Impact of Methamphetamine Use in Washington State (40 min.)

Open video in new tab

Moderator: Caleb Banta-Green, PhD, MPH, MSW, UW Alcohol & Drug Abuse Institute

  • Methamphetamine Trends in Washington State
    Caleb Banta-Green, PhD, MPH, MSW [ 0:00:00 | slides]
  • Key Findings from the 2017 WA State Syringe Exchange Health Survey: Interest in Reducing or Stopping Methamphetamine Use
    Vanessa McMahan, PhD, MS, UW Department of Medicine [0:7:53 | slides]
  • Methamphetamine Use and HIV Among Men Who Have Sex with Men in Seattle, Washington
    Sara Glick, PhD, MPH, Public Health-Seattle & King County [0:19:44 | slides]
  • Q&A with Audience [0:31:00]

Basic Science and Pharmacological Interventions (45 min.)

Open video in new tab

Moderator: Ron Jackson, MSW, LICSW, UW School of Social Work

  • The Pharmacology of Methamphetamine Addiction – Susan Ferguson, PhD, UW Psychiatry & Behavioral Sciences, UW Alcohol & Drug Abuse Institute [0:01:40 | slides]
  • Medication Assisted Treatment for Methamphetamine Use Disorder – Jonathan Buchholz, MD, VA Puget Sound Health Care System, UW Department of Psychiatry [0:13:19 | slides]
  • Q&A with Audience [0:27:15]

Cognitive, Behavioral, and Social Interventions (45 min.)

Open video in new tab

Moderator: Susan Stoner, PhD, UW Alcohol & Drug Abuse Institute

  • Contingency Management: An Evidence-Based, Cost-Effective, Exportable Treatment for Methamphetamine Use – Sterling McPherson, PhD, Washington State University [0:01:19 | slides]
  • Cognitive Behavioral Therapies for Stimulant Use Disorders – Mandy Owens, PhD, UW Alcohol & Drug Abuse Institute [0:11:56 | slides]
  • Psychosocial Interventions to Address Drug- and Sexual-Related Harms Among Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Methamphetamine – Rod Knight, PhD, University of British Columbia, British Columbia Centre on Substance Use [0:23:12 | slides]

Afternoon Session

Addressing Mental Health Needs (25 min.)

Open video in new tab

Moderator: Brad Finegood, MA, LMHC, Public Health-Seattle & King County

  • David Newman, Community Psychiatric Clinic
  • Paul Grekin, MD, Evergreen Treatment Services & Seattle Counseling Service

Supportive Services (30 min.)

Open video in new tab

Moderator: Brad Finegood, MA, LMHC, Public Health-Seattle & King County

  • Noah Fay, MPA, Downtown Emergency Service Center (DESC)
  • Michelle Conley, MSW, REACH Project, Evergreen Treatment Services
  • Charlene “Lena” Takeuchi, LMFT, LMHC, Parent-Child Assistance Program (PCAP)

Harm Reduction Services (45 min.)

Open video in new tab

Moderator: Joe Tinsley, Public Health-Seattle & King County

  • Shilo Jama, People’s Harm Reduction Alliance
  • Pre-Exposure Prophylaxis (PrEP) Use Among Cisgender Men Who Have Sex with Men (MSM) and Use Methamphetamine – Vanessa McMahan, PhD, MS, UW Department of Medicine [0:08:36 | slides]
  • Peter Cleary, Seattle Counseling Service

Going Forward (40 min.)

Open video in new tab

  • Jim Vollendroff, MPA, Harborview UW Medicine Behavioral Health Institute
  • Caleb Banta-Green, PhD, MPH, MSW, UW Alcohol & Drug Abuse Institute [0:29:55 | slides]